NCT03506347View on ClinicalTrials.gov

Regional Prophylactic Vancomycin With Restricted Tourniquet Time in Primary Total Knee Replacement

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

September 24, 2018

Primary Completion Date

January 17, 2019

Study Completion Date

January 17, 2019

Conditions

Arthropathy of Knee Joint

Interventions

DRUG

Vancomycin

Antibiotic

Trial Locations (1)

85259

Mayo Clinic in Arizona, Scottsdale

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER

NCT03506347 - Regional Prophylactic Vancomycin With Restricted Tourniquet Time in Primary Total Knee Replacement | Biotech Hunter | Biotech Hunter